Rapid and quantitative antimalarial drug efficacy testing via the magneto-optical detection of hemozoin
- PMID: 32820190
- PMCID: PMC7441145
- DOI: 10.1038/s41598-020-70860-y
Rapid and quantitative antimalarial drug efficacy testing via the magneto-optical detection of hemozoin
Abstract
Emergence of resistant Plasmodium species makes drug efficacy testing a crucial part of malaria control. Here we describe a novel assay for sensitive, fast and simple drug screening via the magneto-optical detection of hemozoin, a natural biomarker formed during the hemoglobin metabolism of Plasmodium species. By quantifying hemozoin production over the intraerythrocytic cycle, we reveal that hemozoin formation is already initiated by ~ 6-12 h old ring-stage parasites. We demonstrate that the new assay is capable of drug efficacy testing with incubation times as short as 6-10 h, using synchronized P. falciparum 3D7 cultures incubated with chloroquine, piperaquine and dihydroartemisinin. The determined 50% inhibitory concentrations agree well with values established by standard assays requiring significantly longer testing time. Accordingly, we conclude that magneto-optical hemozoin detection provides a practical approach for the quick assessment of drug effect with short incubation times, which may also facilitate stage-specific assessment of drug inhibitory effects.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Health Organization, W. Artemisinin resistance and artemisinin-based combination therapy efficacy (Status report—August 2018).
-
- Eyasu M. Antimalarial drug resistance: in the past, current status and future perspectives. Br. J. Pharmacol. Toxicol. 2015;6:1–15.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
